TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
NRIX

Nurix Therapeutics Inc

Healthcare · Biotechnology

25.50$ +1.4% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Nurix Therapeutics Inc (NRIX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/08/2026.

Next report 10/08/2026
Last report 07/09/2026
Earnings surprise by quarter (%)
Q3 23 · 8.1 % 23 Q4 23 · -54.0 % 23 Q1 24 · 5.0 % 24 Q2 24 · -12.7 % 24 Q3 24 · 1.5 % 24 Q4 24 · -12.1 % 24 Q1 25 · 11.8 % 25 Q2 25 · 29.7 % 25 Q3 25 · -21.2 % 25 Q4 25 · 10.9 % 25 Q1 26 · 4.8 % 26 Q2 26 · -11.0 % 26

EPS estimate beaten

Full history 11 of 25 quarters (44%)
Last 16 quarters 10 of 16 quarters (63%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 07/09/2026 Nurix Therapeutics, Inc. (NRIX): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?